Profusa (PFSA) Convertible Debt (2023 - 2026)

Profusa (PFSA) posted quarterly Convertible Debt of $2.5 million for Q1 2026, up 8.7% quarter-over-quarter from $2.3 million in Q4 2025.

Profusa (PFSA) Convertible Debt (2023 - 2026) Analysis & Trends

Profusa's Convertible Debt history runs 4 years deep, the most recent figure standing at $2.5 million for Q1 2026.

In Q1 2026, Convertible Debt changed N/A year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 4.55% from the prior year.
Convertible Debt for Q1 2026 stood at $2.5 million, up from $2.3 million in the prior quarter.
The five-year high for Convertible Debt was $2.5 million in Q1 2026, with the low at $310999.0 in Q2 2023.
The 4-year median for Convertible Debt is $1.9 million (2024), against an average of $1.6 million.
The sharpest annual moves came in 2024 and 2025: Convertible Debt jumped 182.75% in 2024, then climbed 4.55% in 2025.
Profusa's Convertible Debt stood at $944118.0 in 2023, then surged by 133.02% to $2.2 million in 2024, then increased by 4.55% to $2.3 million in 2025, then grew by 8.7% to $2.5 million in 2026.
Business Quant data shows PFSA's Convertible Debt at $2.5 million in Q1 2026, $2.3 million in Q4 2025, and $2.1 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.24 Bn	196.63 Bn	7.27 Bn
2	Stryker	127.22 Bn	123.74 Bn	4.50 Bn
3	Medtronic	119.02 Bn	109.80 Bn	6.41 Bn
4	Boston Scientific	74.44 Bn	73.90 Bn	3.85 Bn
5	Edwards Lifesciences	51.80 Bn	47.55 Bn	1.35 Bn
6	Dexcom	35.08 Bn	33.13 Bn	830.00 Mn
7	GE HealthCare Technologies	33.82 Bn	31.71 Bn	2.18 Bn
8	Koninklijke Philips	26.24 Bn	22.92 Bn	4.55 Bn
9	Steris	23.18 Bn	22.70 Bn	684.20 Mn
10	Profusa	97,405.06	-277,594.94	-

Download Data